Patent ID: 11883417
Assignee: THE UNIVERSITY OF CHICAGO
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating breast cancer in a patient having breast cancer cells, the method comprising:
a) administering an effective amount of a glucocorticoid receptor antagonist to said patient, wherein said glucocorticoid receptor antagonist is selected from beclometasone, betamethasone, budesonide, ciclesonide, flunisolide, fluticasone, mifepristone, mometasone, triamcinolone, ORG-34517 (Merck), RU-43044, dexamethasone mesylate (Dex-Mes), dexamethasone oxetanone (Dex-Ox), deoxycorticosterone (DOC), CORT 0113083, and CORT 00112716, and wherein the patient expresses a detectable level of glucocorticoid receptor (GR) prior to administration of the GR antagonist;
b) then administering an effective amount of radiation, immunotherapy, or at least one chemotherapeutic agent.